Posted on March 27, 2009 by Sitemaster
The reports addressed today offer information from three very technical studies dealing with:
- Genomic profiling of localized prostate cancers among African American men
- “DNA licensing” and prostate cancer progression
- Interleukin-6 over-expression and bicalutamide resistance … READ MORE …
Filed under: Diagnosis, Drugs in development, Prevention, Risk | Tagged: African American, bicalutamide, DNA licensing, genomic profile, interleukin-6 | Leave a comment »
Posted on March 3, 2009 by Sitemaster
Today’s news covers:
- The ongoing trial of toremifene 20 mg in prevention of prostate cancer
- Interleukin-6 in the development of prostate cancer
- Preservation of the fascia and recovery of erectile function post-surgery
- The use of urethral wall stents and delayed artificial urinary sphincters to treat men with severe, recurrent bladder neck contracture and incontinence after radical prostatectomy … READ MORE …
Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: contracture, erectile function, fascia, incontinence, interleukin-6, PIN, preservation, prostatic intraepithelial neoplasia, sphincter, stent, toremifene | 1 Comment »
Posted on November 30, 2008 by Sitemaster
There are a bunch of new but distinctly technical reports today that will probably be of limited interest to the majority of readers, but in the interests of knowledge please feel free to … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: brachytherapy, cisplatin, Her2, interleukin-6, motion, nanoparticles, prostate, radiotherapy, TrkA, urethra | Leave a comment »